Bausch Health Companies Inc
BHC
Market Cap$2.92B
Close$
$12.03
73.2% upside
Current Fair Value
73.2% upsideUndervalued by 73.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.92 Billion |
|---|---|
| Enterprise Value | $24.26 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.62 |
| Beta | 1.46 |
| Outstanding Shares | 360,989,744 |
| Avg 30 Day Volume | 3,861,832 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.93 |
|---|---|
| PEG | 7.24 |
| Price to Sales | 0.29 |
| Price to Book Ratio | -1.74 |
| Enterprise Value to Revenue | 2.71 |
| Enterprise Value to EBIT | 14.5 |
| Enterprise Value to Net Income | -54 |
| Total Debt to Enterprise | 0.91 |
| Debt to Equity | -19.8 |
Revenue Sources
No data
ESG Score
No data
About Bausch Health Companies Inc
21,100 employeesBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter ...